Healthcare
Shifa Therapy Partners with Mosques and Community Centers to Expand Mental Health Access
Shifa Therapy's partnership with mosques and community centers aims to make culturally sensitive mental health support more accessible to Muslim communities by integrating therapy services into familiar faith-based settings.
MIT and Harvard Researchers Develop Enhanced Natural Killer Cell Therapy for Cancer Treatment
Researchers from MIT and Harvard Medical School have engineered modified natural killer cells that show promising results in fighting cancer while avoiding immune system rejection, potentially transforming cancer immunotherapy approaches.
HeartBeam Receives Buy Rating and $4 Price Target from Roth Capital, Highlighting FDA Clearance Catalyst
HeartBeam Inc. received a Buy rating and $4 price target from Roth Capital, which emphasized the company's potential FDA clearance for its 12-lead ECG synthesis software and its position to transform remote cardiac monitoring.
Cybin Inc. to Present at Guggenheim Healthcare Innovation Conference Amid Phase 3 Mental Health Drug Development
Cybin Inc. announced its participation in the Guggenheim Healthcare Innovation Conference as the company advances its Phase 3 clinical trials for novel mental health treatments, highlighting growing investor interest in innovative neuropsychiatry solutions.
NanoViricides Sets 2025 Annual Shareholders Meeting Amid Clinical Development Push
NanoViricides announced its 2025 shareholders meeting while advancing multiple antiviral drug candidates including NV-387 for respiratory infections and NV-HHV-1 for shingles treatment.
BioUtah Announces 2025 Life Sciences Award Winners Recognizing Utah's Healthcare Innovation Leaders
BioUtah will honor five distinguished individuals and companies at the 2025 Mayer Brown Utah Life Sciences Summit for their transformative contributions to healthcare innovation and economic growth in Utah's life sciences sector.
Las Vegas Emerges as Premier Destination for Luxury Medical Tourism
Signature Plastic Surgery is positioning Las Vegas as a leading destination for high-quality cosmetic surgery, offering patients an alternative to costly metropolitan areas and overseas medical tourism through integrated luxury hospitality experiences.
Austin Chiropractor Prescribes 'Time Out Rx' as Antidote to Modern Burnout Culture
An Austin chiropractor's prescription for strategic pauses addresses the growing epidemic of burnout by focusing on nervous system restoration rather than productivity hacks.
American Heart Association Leverages HBCU Football Game to Promote Cardiac Emergency Preparedness
The American Heart Association used the Battle of the Legends HBCU football game to educate fans about hypertrophic cardiomyopathy and Hands-Only CPR, addressing critical gaps in heart health awareness and emergency response capabilities in underrepresented communities.
Ocumetics Reports Promising Early Results in First Human Lens Implant Study
Ocumetics Technology Corp. announced encouraging one-month vision results from its first human clinical study of an accommodating intraocular lens, showing potential to transform cataract treatment and reduce dependence on corrective lenses.
NeuroOne Granted 180-Day Extension to Regain Nasdaq Compliance
NeuroOne Medical Technologies has received an additional 180 days to meet Nasdaq's minimum bid price requirement, providing crucial breathing room for the neurological device company to stabilize its stock performance and avoid potential delisting.
A Place At Home – North Austin Wins Second Consecutive Best of Round Rock Award
A Place At Home – North Austin has secured the Best of Round Rock Award for the second year, highlighting its community-focused approach to senior care and veteran support through specialized programs and partnerships.
Omaha Chiropractic Clinic Emphasizes Personalized Care and Holistic Wellness Approach
Platinum Chiropractic + Wellness establishes itself as Omaha's premier chiropractic clinic, offering personalized treatment plans and comprehensive wellness services that address root causes of health issues rather than just symptoms.
University of Florida Student Claudia Masmitja Corujo Awarded 2025 Marcus W. Viles Community Growth Scholarship
Claudia Masmitja Corujo, a first-generation college student at the University of Florida, received the $2,500 scholarship for her commitment to community support and healthcare equity, continuing Marcus Viles's legacy of community betterment.
SunKnowledge Expands Virtual Medical Assistant Services Nationwide with Cost-Saving Solutions
SunKnowledge Inc. is transforming healthcare operations across all 50 states by providing specialized virtual medical assistant services that reduce administrative costs by up to 80% while improving efficiency and patient care.
New Guide Aims to Bridge Business Knowledge Gap for Dental Practice Owners
A comprehensive new book by dental consultant Joseph Wineman provides essential operational guidance for dentists transitioning to practice ownership, addressing critical business challenges beyond clinical training.
MEDICLIN Reports Strong Nine-Month Performance with 41.7% Operating Profit Growth
MEDICLIN Aktiengesellschaft demonstrated robust financial performance in the first nine months of 2025, with group operating results surging 41.7% to €48.9 million and sales growing 5.1% to €586.9 million, signaling strong recovery in the healthcare sector despite ongoing cost pressures.
Soligenix Secures Financial Stability Through 2026 to Advance Rare Disease and Biodefense Pipeline
Soligenix has strengthened its financial position with strategic capital initiatives, providing runway through 2026 to advance multiple late-stage therapeutic and vaccine candidates addressing rare diseases and biodefense needs.
Club Pilates Launches National 'Every Body' Campaign to Promote Fitness Inclusivity
Club Pilates has launched its first national brand campaign featuring real members to challenge fitness stereotypes and promote accessibility across all body types and experience levels.
Lung Cancer Screening Rates Remain Critically Low Despite Improved Survival Outcomes
A new report reveals alarmingly low lung cancer screening rates in the U.S. despite recent survival improvements, highlighting a critical gap in early detection for the nation's deadliest cancer.
Kairos Pharma Reports Promising Phase 2 Results for Prostate Cancer Treatment ENV105
Kairos Pharma's ENV105 demonstrates 86% clinical benefit rate in advanced metastatic prostate cancer patients when combined with standard therapy, potentially addressing critical treatment resistance challenges in oncology.
Five Health Tech Finalists Compete to Advance Cardiovascular and Brain Health Solutions
The American Heart Association has selected five innovative health technology companies as finalists in its global competition, highlighting emerging solutions that could significantly impact the prevention and treatment of heart disease and stroke worldwide.
GeoVax to Report Q3 2025 Financial Results and Provide Business Update
GeoVax Labs will report its third quarter 2025 financial results and provide updates on its clinical-stage vaccine and immunotherapy programs, including COVID-19 vaccines for immunocompromised patients and oncology treatments.
Pacylex and Heidelberg Pharma Present Promising Zelenirstat ADC Data at World ADC Conference
Pacylex Pharmaceuticals and Heidelberg Pharma are presenting data showing zelenirstat's potential as a novel antibody drug conjugate payload, demonstrating significantly increased potency against breast and prostate cancer cells compared to oral administration alone.
American Heart Association Recognizes Three Digital Health Innovators in CarePlan Challenge
The American Heart Association has selected three health technology innovators for their digital solutions that integrate clinical guidelines to transform cardiovascular care delivery and improve patient outcomes.
Heights Wellness Retreat Expands to Porter Ranch with Holistic Approach
The opening of Heights Wellness Retreat in Porter Ranch represents a strategic expansion of wellness services in Southern California, offering both traditional and innovative touchless therapies to address growing consumer demand for holistic health solutions.
Heidelberg Pharma Reports Promising Clinical Data for Multiple Myeloma Treatment HDP-101
Heidelberg Pharma will present new clinical data showing objective responses and anti-tumor activity in multiple myeloma patients treated with its lead antibody-drug conjugate candidate HDP-101, highlighting its potential to address significant unmet medical needs in relapsed or refractory cases.
Thomas Meier Appointed as New CEO of Medios AG, Signaling Strategic Growth Phase
Medios AG appoints Thomas Meier as new CEO to drive expansion in the European Specialty Pharma market, bringing international leadership experience from Swiss CDMO Bachem Holding AG.
Sapu Nano Announces First Human Trial of Injectable Everolimus Formulation for Breast Cancer
Sapu Nano has revealed initial human clinical trials for Sapu-003, an intravenous formulation of Everolimus that could offer improved bioavailability and efficacy compared to oral versions for breast cancer treatment.
Soligenix Strengthens CTCL Advisory Board to Advance HyBryte Therapy Development
Soligenix has updated its U.S. Medical Advisory Board for cutaneous T-cell lymphoma to support the clinical advancement of HyBryte and related therapies, reflecting the company's strategic focus on navigating complex regulatory and commercialization challenges in the rare disease space.